Artivion | CRY - Biaya Penjualan

Harga Saham
35.29
Perubahan Harian
-1.10 -3.02%
Bulanan
-8.46%
Tahunan
45.53%
Q1 Perkiraan
35.04




Biaya Penjualan Perubahan Tanggal
Abbott USD 4.92B 535M 2025-12
Accuray USD 116.17M 14.63M 2024-12
AngioDynamics USD 37.29M 786K 2025-09
Artivion USD 42.85M 3.86M 2025-12
AtriCure USD 35.16M 2.23M 2025-12
Baxter International USD 2.4B 512M 2025-12
Becton, Dickinson and Co. USD 2.84B 2.35B 2025-12
Boston Scientific USD 1.84B 82M 2025-12
Edwards Lifesciences USD 343M 2.2M 2025-12
Inogen USD 39.59M 1.27M 2024-09
Integra LifeSciences USD 193.44M 1.62M 2025-12
J&J USD 7.97B 689M 2025-12
Mesa Laboratories USD 21.92M 1.78M 2024-09
Orthofix International USD 66.63M 6.4M 2025-12
Pfizer USD 6.29B 2.12B 2025-12
ResMed USD 555.85M 29.13M 2025-12
Stryker USD 2.69B 373M 2025-12
Surmodics USD 33.03M 24.58M 2024-09
Tandem Diabetes Care USD 122.92M 7.96M 2025-12
Teleflex USD 261.54M 199.84M 2025-12
Terumo JPY 143.44B 15.47B 2025-12
Trinity Biotech USD 7.84M 3.14M 2025-09